Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.

  title={Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.},
  author={Nafiseh Nafissi and Marianna Foldvari},
  journal={Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology},
  volume={8 2},
Glaucoma is a neurodegenerative eye disease that causes permanent blindness at the progressive stage and the number of people affected worldwide is expected to reach over 79 million by 2020. Currently, glaucoma management relies on pharmacological and invasive surgical treatments mainly by reducing the intraocular pressure (IOP), which is the most important risk factor for the progression of the visual field loss. Recent research suggests that neuroprotective or neuroregenerative approaches are… CONTINUE READING